Can-Fite BioPharma Ltd.
1.57
-0.05 (-3.09%)
At close: Jan 15, 2025, 11:06 AM

Can-Fite BioPharma Ltd. Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for CANF stock have an median target of 10, with a low estimate of 10 and a high estimate of 18. The median target predicts an increase of 536.94% from the current stock price of 1.57.

Analyst Consensus: Buy
Target Low Average Median High
Price $10 $12.67 $10 $18
Change 536.94% 707.01% 536.94% 1046.50%

AI Analyst Report

D. Boral Capital has reiterated a Buy rating for C... Unlock content with Pro Subscription

Updated Dec 31, 2024

Rating Jul 24Aug 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 000000
Buy 111112
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 1 1 2

Financial Forecast this Year

Revenue This Year
500.00K
from 743.00K
Increased by -32.7%
Revenue Next Year
5.00M
from 500.00K
Increased by 900.0%
EPS This Year
-1.25
from -1.79
Increased by 30.2%
EPS Next Year
-0.05
from -1.25
Increased by 96.0%